US6149576A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Targeted hysteresis hyperthermia as a method for treating tissue
Assignee: Sirtex Medical Pty Ltd
•
Filing: 1998-10-29
•
Granted: 2000-11-21
•
Expires: 2018-10-29
Abstract
Abstract The present invention provides an improved method for treatment of diseased tissue, which comprises the steps of: (i) selecting at least a magnetic material which has a magnetic heating efficiency of at least about 4.5×10 -8 J.m./A.g, when rotational magnetic field conditions are equal to or less than about 5×10 8 A/m.s; (ii) delivering the magnetic material to a patient's diseased tissue; and (iii) exposing the magnetic material to a rotational magnetic field with a frequency of greater than about 10 kHz and a field strength selected such that the product of field strength, frequency and the radius of the exposed region is less than about 7.5×10 7 A/s to generate hysteresis heat in the diseased tissue.
Inventors
- 👤 Bruce Nathaniel Gray
- 👤 Stephen Keith Jones
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 22:49
CPC Classifications
A; A61; A61N; A61N2/00; A61N2/12; A61N1/00; A61N1/40; A61N1/403; A61N1/406; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5094
Claims Analysis
Total Claims: 52
Claim 1
Independent Claim
100 words
A method for heating a substance, comprising the steps of: (i) inserting at least one magnetic material having a magnetic heating efficiency of at least about 4.5×10 -8 J.m./A.g. when rotational magnetic field conditions are equal to or less than about 5×10 8 A/s in the substance; and (ii) exposing the magnetic material to a rotational magnetic field with a frequency of greater than about 10 kHz and a field strength such that the product of field strength, frequency, and the radius of the exposed region is less than about 7.5×10 7 A/s to generate hysteresis heat in the substance.
Claim 2
Independent Claim
100 words
A method for heating a substance, comprising the steps of: (i) inserting at least one magnetic material having a magnetic heating efficiency of at least about 4.5×10 -8 J.m./A.g. when rotational magnetic field conditions are equal to or less than about 5×10 8 A/s in the substance; and (ii) exposing the magnetic material to a rotational magnetic field with a frequency of greater than about 10 kHz and a field strength such that the product of field strength, frequency, and the radius of the exposed region is less than about 7.5×10 7 A/s to generate hysteresis heat in the substance.
Claim 3
Dependent Claim
11 words
The method of claim 1, wherein the substance is non-biological material.
Claim 4
Independent Claim
103 words
A method for treating biological tissue, comprising the steps of: (i) introducing at least one magnetic material which has a magnetic heating efficiency of at least about 4.5×10 -8 J.m./A.g. when rotational magnetic field conditions are equal to or less than about 5×10 8 A/s into the biological tissue; and (ii) exposing the magnetic material to a rotational magnetic field with a frequency of greater than about 10 kHz and a field strength selected such that the product of field strength, frequency, and the radius of the exposed region is less than about 7.5×10 7 A/s to generate hysteresis heat in the tissue.
Claim 5
Independent Claim
103 words
A method for treating biological tissue, comprising the steps of: (i) introducing at least one magnetic material which has a magnetic heating efficiency of at least about 4.5×10 -8 J.m./A.g. when rotational magnetic field conditions are equal to or less than about 5×10 8 A/s into the biological tissue; and (ii) exposing the magnetic material to a rotational magnetic field with a frequency of greater than about 10 kHz and a field strength selected such that the product of field strength, frequency, and the radius of the exposed region is less than about 7.5×10 7 A/s to generate hysteresis heat in the tissue.
Claim 6
Dependent Claim
16 words
The method of claim 3, wherein the tissue contains cancerous growths or one or more tumours.
Claim 7
Dependent Claim
23 words
The method of claim 4, wherein step (ii) is carried out for sufficient time to raise the tissue's temperature above about 42° C.
Claim 8
Dependent Claim
20 words
The method of claim 4, wherein the magnetic material is introduced into the tissue via arterial or venus blood supply.
Claim 9
Dependent Claim
20 words
The method of claim 4, wherein said exposing produces a rate of tissue heating greater than 60 mW/cm 3 .
Claim 10
Dependent Claim
18 words
The method of claim 7, wherein the rate of tissue heating is greater than 80 mW/cm 3 .
Claim 11
Dependent Claim
18 words
The method of claim 7, wherein the rate of tissue heating is greater than 100 mW/cm 3 .
Claim 12
Dependent Claim
17 words
The method of claim 4, wherein the magnetic material is bound in a matrix to form microcapsules.
Claim 13
Dependent Claim
29 words
The method of claim 10, wherein the microcapsules are of a size large enough to pass through a patient's vasculature network and become dispersed and embolized within the tissue.
Claim 14
Dependent Claim
19 words
The method of claim 10, wherein the microcapsules are delivered to the tissue in conjunction with a vasoactive agent.
Claim 15
Dependent Claim
27 words
The method of claim 10, wherein the microcapsules are adapted to bind or absorb or contain a cytotoxic material which is released upon heating of the microcapsule.
Claim 16
Dependent Claim
35 words
The method of claim 10, wherein two or more different magnetic materials is introduced to the tissue, the different magnetic materials having different magnetic heating efficiency properties and bound in different matrices to form microcapsules.
Claim 17
Dependent Claim
21 words
The method of claim 14, wherein at least one of the microcapsules is adapted to release chemical, chemotherapeutic, or therapeutic substances.
Claim 18
Dependent Claim
33 words
The method of claim 10, wherein steps (i) to (ii) are repeated until the tissue or part thereof has been killed or treated sufficiently to reduce the size of the growth or tumor.
Claim 19
Dependent Claim
23 words
The method of claim 10, wherein the microcapsules are larger than about 10 microns in diameter but are smaller than about 500 microns.
Claim 20
Dependent Claim
18 words
The method of claim 10, wherein the microcapsules range in diameter from about 10 to about 100 microns.
Claim 21
Dependent Claim
18 words
The method of claim 10, wherein the microcapsules range in diameter from about 20 to about 50 microns.
Claim 22
Dependent Claim
18 words
The method of claim 10, wherein the microcapsules range in diameter from about 30 to about 40 microns.
Claim 23
Dependent Claim
28 words
The method of claim 10, wherein the microcapsules have a density which is sufficiently low to allow the microcapsules to be carried by the bloodstream in a patient.
Claim 24
Dependent Claim
21 words
The method of claim 10, wherein the microcapsules have a density in the range of 1 to 5 g/cm 3 .
Claim 25
Dependent Claim
21 words
The method of claim 10, wherein the microcapsules have a density in the range of 1.8 to 3 g/cm 3 .
Claim 26
Dependent Claim
21 words
The method of claim 10, wherein the microcapsules have a density in the range of 1.8 to 2.2 g/cm 3 .
Claim 27
Dependent Claim
17 words
The method of claim 10, wherein the microcapsules have a density of about 2 g/cm 3 .
Claim 28
Dependent Claim
30 words
The method of claim 3, wherein the magnetic material is constrained by a matrix material that does not adversely effect hysteresis or eddy current heating properties of the magnetic material.
Claim 29
Dependent Claim
35 words
The method of claim 3, wherein the magnetic material has a magnetic heating efficiency of greater than about 7×10 -8 J.m./A.g., when magnetic field conditions are equal to or less than about 5×10 8 A/s.
Claim 30
Dependent Claim
35 words
The method of claim 3, wherein the magnetic material has a magnetic heating efficiency of greater than about 1×10 -7 J.m./A.g., when magnetic field conditions are equal to or less than about 5×10 8 A/s.
Claim 31
Dependent Claim
28 words
The method of claim 3, wherein the magnetic material comprises ferromagnetic materials which include an element selected from the group consisting of iron, manganese, arsenic, antimony, and bismith.
Claim 32
Dependent Claim
73 words
The method of claim 3, wherein the magnetic material is selected from at least one of the following classes of material: CrO 2 ; gamma-ferric oxide (both cobalt treated and non-treated); metallic iron, cobalt, or nickel; ferrites of the general formula MO.Fe 2 O 3 where M is a bivalent metal; cobalt-treated ferrites; or magnetoplumbite-type oxides (M type) with the general formula MO.6Fe 2 O 3 where M is a large divalent ion.
Claim 33
Dependent Claim
19 words
The method of claim 3, wherein the magnetic material comprises cobalt-treated gamma-ferric oxide, a cobalt-treated ferrite, or chromium dioxide.
Claim 34
Dependent Claim
16 words
The method of claim 3, wherein the frequency is from about 10 kHz to 100 MHz.
Claim 35
Dependent Claim
16 words
The method of claim 3, wherein the frequency is from about 10 kHz to 500 kHz.
Claim 36
Dependent Claim
16 words
The method of claim 3, wherein the frequency is from about 10 kHz to 100 kHz.
Claim 37
Dependent Claim
11 words
The method of claim 3, wherein the frequency is 20 kHz.
Claim 38
Dependent Claim
22 words
The method of claim 3, wherein the magnetic material is mixed in a biocompatible liquid emulsion prior to delivery into a patient.
Claim 39
Dependent Claim
20 words
The method of claim 3, wherein an ionizing radiation is applied to the tissue in conjunction with the magnetic field.
Claim 40
Dependent Claim
17 words
The method of claim 37, wherein the radiation is applied by microcapsules which contain a radioactive compound.
Claim 41
Dependent Claim
21 words
The method of claim 3, wherein the magnetic material is bound together using a copolymer of (R)-3-hydroxybutyric acid and (R)-3-hydroxyvaleric acid.
Claim 42
Dependent Claim
36 words
The method of claim 3, wherein the microcapsules are bound together using a copolymer of (R)-3-hydroxybutyric acid and (R)-3-hydroxyvaleric acid, having a density range of 1.8-2.2 g/cm 3 , and range in size from 20-50 microns.
Claim 43
Dependent Claim
31 words
The method of claim 3, wherein the magnetic material is delivered to the tissue by one of the administration methods selected from the group consisting of: intratumoral, peritumoral, or intravascular administrations.
Claim 44
Independent Claim
97 words
A method for generating hysteresis heat in a tissue, comprising: delivering to the tissue magnetic material having a magnetic heating efficiency of at least about 4.5×10 -8 J.m./A.g., when the rotational magnetic field conditions are about 5×10 8 A/s or less; and exposing the tissue, containing the delivered magnetic material, to a rotational magnetic field with a frequency of about 10 kHz or greater and a field strength such that the product of field strength, frequency, and the radius of the exposed tissue is less than about 7.5×10 7 A/s to generate hysteresis heat in the tissue.
Claim 45
Independent Claim
97 words
A method for generating hysteresis heat in a tissue, comprising: delivering to the tissue magnetic material having a magnetic heating efficiency of at least about 4.5×10 -8 J.m./A.g., when the rotational magnetic field conditions are about 5×10 8 A/s or less; and exposing the tissue, containing the delivered magnetic material, to a rotational magnetic field with a frequency of about 10 kHz or greater and a field strength such that the product of field strength, frequency, and the radius of the exposed tissue is less than about 7.5×10 7 A/s to generate hysteresis heat in the tissue.
Claim 46
Dependent Claim
20 words
The method of claim 42, wherein the tissue contains at least a cancerous growth or contains one or more tumor.
Claim 47
Dependent Claim
22 words
The method of claim 43, wherein said delivery and exposure are repeated until said cancerous growth or tumor is reduced in size.
Claim 48
Independent Claim
105 words
A method for the treatment of cancerous growth or tumors, comprising: delivering to a tissue containing a cancerous growth or tumor, a magnetic material having a magnetic heating efficiency of at least about 4.5×10 -8 J.m./A.g., when the rotational magnetic field conditions are about 5×10 8 A/s or less; and exposing the tissue, containing the delivered magnetic material, to a rotating magnetic field with a frequency of about 10 kHz or greater and a field strength such that the product of field strength, frequency, and the radius of the exposed tissue is less than about 7.5×10 7 A/s to generate hysteresis heat in the tissue.
Claim 49
Independent Claim
105 words
A method for the treatment of cancerous growth or tumors, comprising: delivering to a tissue containing a cancerous growth or tumor, a magnetic material having a magnetic heating efficiency of at least about 4.5×10 -8 J.m./A.g., when the rotational magnetic field conditions are about 5×10 8 A/s or less; and exposing the tissue, containing the delivered magnetic material, to a rotating magnetic field with a frequency of about 10 kHz or greater and a field strength such that the product of field strength, frequency, and the radius of the exposed tissue is less than about 7.5×10 7 A/s to generate hysteresis heat in the tissue.
Claim 50
Dependent Claim
44 words
A composition comprising: a magnetic material having a magnetic heating efficiency of at least about 4.5×10 -8 J.m./A.g., when the magnetic field conditions are about 5×10 8 A/s or less; and a matrix-forming polymer; wherein the magnetic material is encapsulated in the polymeric matrix.
Claim 51
Dependent Claim
44 words
A composition comprising: a magnetic material having a magnetic heating efficiency of at least about 4.5×10 -8 J.m./A.g., when the magnetic field conditions are about 5×10 8 A/s or less; and a matrix-forming polymer; wherein the magnetic material is encapsulated in the polymeric matrix.
Claim 52
Dependent Claim
10 words
The composition of claim 46, further comprising a cytotoxic agent.
References Cited (Backward Citations)
US4106488A
Cited
US4303636A
Cited
US4323056A
Cited
US4545368A
Cited
US4662359A
Cited
US4983159A
Cited
US5411730A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-11-21 | 2004-05-22 | 2004-11-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-11-21 | 2008-05-22 | 2008-11-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-11-21 | 2012-05-22 | 2012-11-21 | $7700.00 | Window Closed / Lapsed |